Details for Patent: 9,079,928
✉ Email this page to a colleague
Which drugs does patent 9,079,928 protect, and when does it expire?
Patent 9,079,928 protects AZSTARYS and is included in one NDA.
This patent has fifty-four patent family members in twenty-eight countries.
Summary for Patent: 9,079,928
| Title: | Methylphenidate-oxoacid conjugates, processes of making and using the same |
| Abstract: | The present technology is directed to prodrugs and compositions for the treatment of various diseases and/or disorders comprising methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof. In some embodiments, the conjugates further include at least one linker. The present technology also relates to the synthesis of methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof or combinations thereof. |
| Inventor(s): | Guenther; Sven (Coralville, IA), Chi; Guochen (Coralville, IA), Bera; Bindu (Blacksburgh, VA), Mickle; Travis (Coralville, IA), Bera; Sanjib (Blacksburg, VA) |
| Assignee: | KemPharm, Inc. (Coralville, IA) |
| Application Number: | 14/234,440 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,079,928
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-001 | May 7, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-002 | May 7, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Commave Therap | AZSTARYS | dexmethylphenidate hydrochloride; serdexmethylphenidate chloride | CAPSULE;ORAL | 212994-003 | May 7, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,079,928
| PCT Information | |||
| PCT Filed | July 27, 2012 | PCT Application Number: | PCT/US2012/048641 |
| PCT Publication Date: | January 31, 2013 | PCT Publication Number: | WO2013/016668 |
International Family Members for US Patent 9,079,928
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 087390 | ⤷ Try a Trial | |||
| Australia | 2012286683 | ⤷ Try a Trial | |||
| Brazil | 112014002084 | ⤷ Try a Trial | |||
| Canada | 2837732 | ⤷ Try a Trial | |||
| Canada | 2984544 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
